Skip to main content

Table 1 Baseline characteristics of the study collective

From: Left atrial appendage morphology, echocardiographic characterization, procedural data and in-hospital outcome of patients receiving left atrial appendage occlusion device implantation: a prospective observational study

 

Watchman

ACP 2

All

p Value

Patients, n (%)

22 (59.5)

15 (40.5)

37 (100)

-

Male, n (%)

16 (72.7)

9 (60)

25 (67.6)

0.417

Age, y (IQR)

77 (70.75–81)

80 (76–83)

79 (71.5–81.5)

0.213

Height, cm (IQR)

170 (167.75–177)

170 (165–172)

170 (167–175)

0.090

Weight, kg (IQR)

80.5 (67.5–90)

83.5 (69.75–93.25)

81.5 (69.25–90)

0.531

Reason for not taking OAC, n (%)

    

 - GI bleeding

8 (36.4)

8 (53.8)

16 (43.2)

0.306

 - ICB

4 (18.2)

2 (13.3)

6 (16.2)

0.694

 - Muscle bleeding

2 (9.1)

0 (0)

2 (5.4)

0.230

 - Other bleeding localization

2 (9.1)

3 (20)

5 (13.5)

0.341

 - Refusal

3 (13.6)

0 (0)

3 (8.1)

0.136

 - Other causes

3 (13.6)

2 (13.3)

5 (13.5)

1.000

AF type, n (%)

    

 - Paroxysmal

12 (54.5)

7 (46.7)

19 (51.4)

0.638

 - Persistent

2 (9.1)

3 (20)

5 (13.5)

0.341

 - Permanent

8 (36.4)

5 (33.3)

13 (35.1)

0.850

Heart rhythm at hospitalization, n (%)

    

 - SR

6 (27.3)

6 (40)

12 (32.4)

0.225

 - AF

12 (54.5)

9 (60)

21 (56.8)

0.742

 - PM

2 (9.1)

0 (0)

2 (5.4)

0.230

 - unsp.

2 (9.1)

0 (0)

2 (5.4)

0.230

Prior PVI, n (%)

2 (9.1)

1 (6.7)

3 (8.1)

0.791

Hypertension, n (%)

21 (95.5)

15 (100)

36 (97.3)

0.403

Diabetes mellitus, n (%)

6 (27.3)

6 (40)

12 (32.4)

0.417

TIA, n (%)

4 (18.2)

0 (0)

4 (10.8)

0.080

Stroke, n (%)

1 (4.5)

2 (13.3)

3 (8.11)

0.336

Coronary artery disease, n (%)

13 (59.1)

8 (53.3)

21 (56.8)

0.729

Peripheral vascular disease, n (%)

3 (13.6)

1 (6.7)

4 (10.8)

0.503

Renal failure, n (%)

8 (36.4)

5 (33.3)

13 (35.1)

0.850

 - GFR (IQR)

70 (43.5–70)

70 (41–70)

70 (42–70)

0.636

Liver failure, n (%)

3 (13.6)

1 (6.7)

4 (10.8)

0.503

Prior bleeding, n (%)

16 (72.7)

13 (86.7)

29 (78.4)

0.312

Labile INR, n (%)

2 (9.1)

1 (6.7)

3 (8.1)

0.791

CHA2DS2-VASc score (IQR)

4 (3–5)

5 (3–5)

5 (3–5)

0.292

HAS-BLED score (IQR)

4 (3–5)

4 (3–4)

4 (3–5)

0.538

Baseline OAC, n (%)

    

 - None

10 (45.5)

9 (60)

19 (51.4)

0.385

 - Warfarin

3 (13.6)

3 (20)

6 (16.2)

0.606

 - Rivaroxaban

6 (27.3)

2 (13.3)

8 (21.6)

0.312

 - Dabigatran

1 (4.5)

1 (6.7)

2 (5.4)

0.779

 - Apixaban

2 (9.1)

0 (0)

2 (5.4)

0.230

Cardiac device, n (%)

    

 - PM

4 (18.2)

3 (20)

7 (18.9)

0.890

 - ICD

1 (4.5)

2 (13.3)

3 (8.1)

0.336

  1. Values are given as medians (25th and 75th percentiles) or total numbers (percentage). AF atrial fibrillation, GFR glomerular filtration rate, GI gastrointestinal, ICB intracerebral bleeding, ICD implantable cardioverter defibrillator, INR international normalized ratio, OAC oral anticoagulation, PM pacemaker, PVI pulmonary vein isolation, SR sinus rhythm, TIA transient ischemic attack, unsp. unspecified
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us